Newswise — April 19, 2021 – An estimated 50 million people undergo surgery each year in the United States, and a significant proportion of them have undiagnosed or untreated sleep disorders (SD) or sleep-disordered breathing (SDB). Issues at the intersection of anesthesiology and sleep medicine are the focus of the Society of Anesthesia and Sleep Medicine (SASM) whose 10th anniversary is commemorated in the special theme May issue of Anesthesia & Analgesia.
The special issue looks back at a remarkable first decade of achievements in research and clinical practice by this young subspecialty society, while looking forward to further progress. A key focus is the potential for treating surgery and the perioperative period as an opportunity for recognition, diagnosis and effective treatment of patients with undiagnosed SD or SDB, according to an editorial by Satya Krishna Ramachandran, MD, Associate Professor of Anaesthesia at Harvard Medical School and President of SASM.
New insights on sleep apnea surgery, postoperative respiratory depression and more
The SASM theme issue presents 15 papers on key issues related to anesthesia and surgical management of patients with SD or SDB. Eric Brian Rosero, MD, MSc, and Girish P. Joshi, MBBS, MD, of University of Texas Southwestern Medical Center, Dallas, analyzed the outcomes of 3,208 patients undergoing sleep apnea surgery.
The study focused on complications and other outcomes for patients undergoing inpatient versus outpatient surgery. About two-thirds of patients had inpatient surgery, spending at least one night in the hospital. On initial analysis, the inpatient surgery group had a higher rate of hospital readmissions, repeat surgery, and complications: 6.8 versus 5.5 percent.
However, on further analysis of patients with similar risk factors (age, health conditions, etc.), the rate of adverse outcomes was almost identical for the inpatient and outpatient groups: 6.2 versus 5.9 percent. Certain factors were associated with a higher rate of adverse events, including diabetes and more complex surgery. "These risk factors could be used to determine the need for an overnight stay," Drs. Rosero and Joshi conclude.
A study led by Toby N. Weingarten, MD, of the Mayo Clinic, Rochester, Minn., used data from a previous study of patients undergoing continuous bedside monitoring after surgery to assess the occurrence of episodes of postoperative respiratory depression (RD). While postoperative RD events were once considered uncommon, recent studies suggest that they may occur in more than 40 percent of patients and often go unrecognized.
From the total of 250 patients, the researchers identified 155 patients with a total of more than 2,500 RD episodes within the first 24 hours after surgery. Initial RD episodes tended to occur within the first several hours after surgery. These initial episodes peaked in the late afternoon and early evening, often followed by repeated episodes during the early morning hours.
The rate and frequency of postoperative RD episodes were greater for patients who scored higher on a risk scale used in the original study. Dr. Weingarten and colleagues believe their unique data may have important implications for research and clinical practice, including the development of new postoperative monitoring strategies.
In his editorial, Dr. Ramachandran focuses on strategies to promote diagnosis and treatment of unrecognized sleep disorders in patients undergoing anesthesia and surgery. He writes, "If we in anesthesiology are indeed committed towards the fundamental tenets of perioperative medicine, the import of using the perioperative period to diagnose and initiate long-term medical care of SD or SDB cannot be overstated."
Assembled by invitation from the editors of Anesthesia & Analgesia, the SASM theme issue celebrates "a decade of research achievements in the common ground between sleep and anesthesia," according to an introductory editorial by Dr. Weingarten and his fellow guest editors. They add: "Among other things, these studies build the case for greater awareness of sleep issues among anesthesiologists and enhanced sleep training in anesthesia."
DOI: 10.1213/ANE.0000000000005478
###
Anesthesia & Analgesia is published by Wolters Kluwer.
View the article collection from Anesthesia & Analgesia.
About Anesthesia & Analgesia
Anesthesia & Analgesia was founded in 1922 and was issued bi-monthly until 1980, when it became a monthly publication. A&A is the leading journal for anesthesia clinicians and researchers and includes more than 500 articles annually in all areas related to anesthesia and analgesia, such as cardiovascular anesthesiology, patient safety, anesthetic pharmacology, and pain management. The journal is published on behalf of the IARS by Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer, Health.
About the IARS
The International Anesthesia Research Society is a nonpolitical, not-for-profit medical society founded in 1922 to advance and support scientific research and education related to anesthesia, and to improve patient care through basic research. The IARS contributes nearly $1 million annually to fund anesthesia research; provides a forum for anesthesiology leaders to share information and ideas; maintains a worldwide membership of more than 15,000 physicians, physician residents, and others with doctoral degrees, as well as health professionals in anesthesia related practice; sponsors the SmartTots initiative in partnership with the FDA; supports the resident education initiative OpenAnesthesia; and publishes two journals, Anesthesia & Analgesia and A&A Case Reports.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2020 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
RSS